Methyldienedione
Sopomenke: Estra-4,9-Diene-3,17-Dione
CAS: 5173-46-6
MF: C18H22O2
MW: 270.37
Test: 99%
Znak: Bel kristalinični prah.
Pakiranje:Foil bag or as requirments
kategorije: Farmacevtski intermediati; Aminokisline; Intermediati & Fine kemikalije; Metaboliti & Nečistoče; Farmacevtski izdelki; Steroidi
Uporaba: Potencialni presnovek STS 557 (Dienogest). Steroid z antiglukokortikoidnim delovanjem.
Estra-4,9-diene-3,17-dione is a powerful pro-steroid chemically similar to the anabolic agent Trenbolone.
When in the body, estra-4,9-diene-3,17-dione completes the conversion to Trenbolone. Trenbolone is a potent anabolic steroid, which binds to specific receptors present in reproductive tissue, muscle and fat.
Estra Diene Dione (estra-4,9-diene-3,17-dione) is an anabolic steroid and a precursor to Estra Diene Dione. It became a controlled substance in the US on January 4, 2010, and is classified as a Schedule III anabolic steroid under the United States Controlled Substances Act. Previous to this, it was sold as a bodybuilding supplement within the United States, and often mistakenly marketed as a prohormone for trenbolone, a veterinary steroid. Prior to its scheduling, it was part of a number of supplements that were seized during FDA enforcement for selling unapproved new drugs. The actual target steroid, Estra Diene Dione has some structural similarity to trenbolone, but lacks the 11-carbon -ene bond.
1. Protection from gynomastia,
2. Increased sex drive/libido,
3. Enhanced intensity & fokus,
4. Estrogen control,
5. Positive effects on strength & lean mass.
It offers benefits such as improvements in male fertility, ravni razpoloženja, skrajšano okrevanje v primeru opeklin ali hudih poškodb in stimulacija pri sesalcih v razvoju. Velja za učinkovitejšo snov proti aromatazi kot mnoge druge in je dovolj močna, da poveča raven testosterona v telesu brez sočasnega zmanjšanja ravni estrogena pri moških. Uporablja se lahko za hormonsko ali androgensko nadomestno zdravljenje pri moških, ne da bi povzročil sočasno znižanje ravni endogenega estrogena, če ga dajemo peroralno ali transdermalno v odmerkih od 25-150 mg/dan.